Table 1.
The in vitro antiproliferative activities of quinolines, ketoprofen and cisplatin against A2780 (drug-sensitive ovarian carcinoma cells) and A2780/RCIS (multidrug resistant ovarian carcinoma cells)
a Compound concentration required to inhibit tumor cell proliferation by 50%. Data are presented as the mean ± SD from the dose−response curves of three independent experiments
